Sg3 Management, LLC Abb Vie Inc. Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $1.34 Million - $1.7 Million	12,500 Added 357.14%	16,000 $2.17 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $904,400 - $1.03 Million	-8,500 Reduced 70.83%	3,500 $378,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $841,680 - $937,680	-8,000 Reduced 40.0%	12,000 $1.35 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1.47 Million - $1.96 Million	20,000 New	20,000 $1.96 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.